SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AC0. A total of 25 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $78,718,000 | +50.1% | 21,200,000 | 0.0% | 1.09% | +62.1% |
| Q4 2014 | $52,430,000 | -44.6% | 21,200,000 | -24.8% | 0.67% | -46.4% |
| Q3 2014 | $94,629,000 | +25.6% | 28,200,000 | 0.0% | 1.25% | +36.2% |
| Q2 2014 | $75,347,000 | +19.2% | 28,200,000 | 0.0% | 0.92% | +15.2% |
| Q1 2014 | $63,221,000 | +53.0% | 28,200,000 | +34.3% | 0.80% | +61.1% |
| Q4 2013 | $41,318,000 | +238.0% | 21,000,000 | +162.5% | 0.49% | +282.9% |
| Q3 2013 | $12,225,000 | +46.0% | 8,000,000 | +45.5% | 0.13% | +55.4% |
| Q2 2013 | $8,374,000 | – | 5,500,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 219,440,000 | $431,748,000 | 6.08% |
| SYMPHONY ASSET MANAGEMENT LLC | 12,727,000 | $25,040,000 | 1.83% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,000,000 | $41,318,000 | 0.49% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 600,000 | $1,184,000 | 0.48% |
| SHENKMAN CAPITAL MANAGEMENT INC | 200,000 | $395,000 | 0.04% |
| Citadel Advisors | 11,000,000 | $21,696,000 | 0.03% |
| PEAK6 Group LLC | 15,000 | $2,951,000 | 0.02% |
| FRANKLIN RESOURCES INC | 17,290,000 | $34,071,000 | 0.02% |
| LORD, ABBETT & CO. LLC | 3,243,000 | $6,397,000 | 0.01% |
| EULAV Asset Management | 123,000 | $242,000 | 0.01% |